Tenaya Therapeutics (TNYA) Short Interest Ratio & Short Volume $1.13 -0.03 (-2.59%) Closing price 04:00 PM EasternExtended Trading$1.16 +0.03 (+2.65%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tenaya Therapeutics Short Interest DataTenaya Therapeutics (TNYA) has a short interest of 10.61 million shares, representing 7.89% of the float (the number of shares available for trading by the public). This marks a 4.02% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.3, indicating that it would take 4.3 days of the average trading volume of 4.01 million shares to cover all short positions.Current Short Interest10,610,000 sharesPrevious Short Interest10,200,000 sharesChange Vs. Previous Month+4.02%Dollar Volume Sold Short$7.17 millionShort Interest Ratio4.3 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares162,980,000 sharesFloat Size134,430,000 sharesShort Percent of Float7.89%Today's Trading Volume2,334,698 sharesAverage Trading Volume4,008,895 sharesToday's Volume Vs. Average58% Short Selling Tenaya Therapeutics? Sign up to receive the latest short interest report for Tenaya Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTNYA Short Interest Over TimeTNYA Days to Cover Over TimeTNYA Percentage of Float Shorted Over Time Tenaya Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/202510,610,000 shares $7.17 million +4.0%7.9%4.3 $0.68 7/15/202510,200,000 shares $7.04 million -4.7%7.6%4.1 $0.69 6/30/202510,700,000 shares $6.54 million -10.0%8.0%4.5 $0.61 6/15/202511,890,000 shares $7.03 million -1.3%8.9%4.9 $0.59 5/31/202512,050,000 shares $5.45 million -0.9%9.0%3.9 $0.45 5/15/202512,160,000 shares $5.32 million +39.3%9.1%3.5 $0.44 4/30/20258,730,000 shares $4.15 million -0.5%6.5%2.6 $0.48 4/15/20258,770,000 shares $4.45 million -19.0%6.5%2.7 $0.51 3/31/202510,820,000 shares $6.17 million -3.6%8.1%3.2 $0.57 3/15/202511,220,000 shares $7.84 million -22.1%8.4%3 $0.70 Get the Latest News and Ratings for TNYA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tenaya Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/28/202514,400,000 shares $14.54 million +7.7%11.3%3.4 $1.01 2/15/202513,370,000 shares $16.04 million +9.2%20.5%3.4 $1.20 1/31/202512,240,000 shares $12.97 million +6.6%18.7%2.8 $1.06 1/15/202511,480,000 shares $16.88 million -7.6%17.5%2.4 $1.47 12/31/202412,420,000 shares $17.76 million -25.6%18.9%2.6 $1.43 12/15/202416,690,000 shares $45.90 million +18.8%25.4%3.8 $2.75 11/30/202414,050,000 shares $50.16 million +7.1%21.4%4.8 $3.57 11/15/202413,120,000 shares $25.85 million +150.4%20.0%5.7 $1.97 10/31/20245,240,000 shares $10.06 million +7.4%8.0%3.4 $1.92 10/15/20244,880,000 shares $8.25 million -3.9%7.5%10.6 $1.69 9/30/20245,080,000 shares $9.80 million -2.7%7.8%12.9 $1.93 9/15/20245,220,000 shares $10.44 million +11.1%8.0%12.6 $2.00 8/31/20244,700,000 shares $12.60 million +1.5%7.2%12.4 $2.68 8/15/20244,630,000 shares $13.89 million +4.5%7.1%12.4 $3.00 7/31/20244,430,000 shares $15.51 million +0.9%6.8%12 $3.50 7/15/20244,390,000 shares $15.45 million +12.9%6.7%12.4 $3.52 6/30/20243,890,000 shares $12.06 million +15.1%6.0%11 $3.10 6/15/20243,380,000 shares $11.36 million -1.7%5.2%11.1 $3.36 5/31/20243,440,000 shares $14.48 million +2.7%5.3%9.1 $4.21 5/15/20243,350,000 shares $14.24 million -7.7%5.1%7.8 $4.25 4/30/20243,630,000 shares $16.48 million +7.7%5.8%7.2 $4.54 4/15/20243,370,000 shares $15.06 million +9.1%5.4%6.2 $4.47 3/31/20243,090,000 shares $16.16 million +21.2%5.0%5.1 $5.23 3/15/20242,550,000 shares $12.69 million -10.2%4.1%4.1 $4.98 2/29/20242,840,000 shares $16.90 million +14.5%4.7%5 $5.95 2/15/20242,480,000 shares $14.33 million -7.5%4.1%4.7 $5.78 1/31/20242,680,000 shares $11.27 million +14.0%6.0%5.9 $4.21 1/15/20242,350,000 shares $7.19 million -0.8%5.2%5.6 $3.06 12/31/20232,370,000 shares $7.68 million +19.7%5.3%6.8 $3.24 12/15/20231,980,000 shares $4.12 million -23.6%4.4%5.4 $2.08Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow 11/30/20232,590,000 shares $4.87 million +5.3%5.8%6.9 $1.88 11/15/20232,460,000 shares $4.48 million -16.6%5.5%7.2 $1.82 10/31/20232,950,000 shares $5.37 million -2.0%6.6%8.6 $1.82 10/15/20233,010,000 shares $6.89 million -8.8%6.7%8.6 $2.29 9/30/20233,300,000 shares $8.42 million +3.1%7.4%9.4 $2.55 9/15/20233,200,000 shares $10.27 million +9.6%7.1%9.7 $3.21 8/31/20232,920,000 shares $11.30 million +3.6%6.6%9 $3.87 8/15/20232,820,000 shares $11.03 million +11.9%6.3%7.3 $3.91 7/31/20232,520,000 shares $12.20 million -23.9%6.2%5.2 $4.84 7/15/20233,310,000 shares $18.17 million +5.4%8.1%5 $5.49 6/30/20233,140,000 shares $18.43 million +6.4%7.7%4.6 $5.87 6/15/20232,950,000 shares $19.77 million +20.4%7.2%4.5 $6.70 5/31/20232,450,000 shares $17.64 million +18.9%6.0%3.7 $7.20 5/15/20232,060,000 shares $14.42 million +30.4%5.0%3.2 $7.00 4/30/20231,580,000 shares $8.40 million -6.5%3.9%2.6 $5.32 4/15/20231,690,000 shares $4.85 million +1.8%4.1%3.6 $2.87 3/31/20231,660,000 shares $4.73 million +84.6%4.2%4.7 $2.85 3/15/2023899,400 shares $2.36 million +14.9%2.3%2.5 $2.63 2/28/2023782,600 shares $2.40 million -10.3%2.1%2.7 $3.07 2/15/2023872,200 shares $2.67 million +3.9%2.3%2.7 $3.06 1/31/2023839,400 shares $2.87 million -2.4%2.1%2.3 $3.42 1/15/2023859,600 shares $1.97 million +2.4%2.2%2.8 $2.29 12/30/2022839,300 shares $1.69 million -15.2%2.1%3.1 $2.01 12/15/2022990,000 shares $2.35 million -14.7%2.0%3.6 $2.37 11/30/20221,160,000 shares $3.07 million -10.1%2.7%4.4 $2.65 11/15/20221,290,000 shares $3.78 million -0.8%3.1%5.6 $2.93 10/31/20221,300,000 shares $3.48 million -13.3%4.6%8.2 $2.68 10/15/20221,500,000 shares $3.69 million -1.3%5.3%9.3 $2.46 9/30/20221,520,000 shares $4.41 million No Change5.4%8.8 $2.90 9/15/20221,520,000 shares $6.10 million -6.2%5.4%8.4 $4.01 8/31/20221,620,000 shares $7.11 million -10.0%5.7%9.6 $4.39 8/15/20221,800,000 shares $10.31 million -26.8%6.4%10.9 $5.73 7/31/20222,460,000 shares $11.73 million No Change8.7%16.8 $4.77 7/15/20222,460,000 shares $12.79 million -39.0%8.7%19 $5.20 6/30/20224,030,000 shares $22.69 million +7.2%14.3%34.8 $5.63 6/15/20223,760,000 shares $20.45 million +1.6%13.3%34.6 $5.44 5/31/20223,700,000 shares $24.79 million -1.1%13.1%27.8 $6.70 5/15/20223,740,000 shares $26.55 million -0.5%13.3%25.4 $7.10 4/30/20223,760,000 shares $34.67 million +1.1%13.3%24.4 $9.22 4/15/20223,720,000 shares $42.56 million +1.6%13.2%22.7 $11.44 3/31/20223,660,000 shares $43.11 million +13.3%13.0%19.9 $11.78 3/15/20223,230,000 shares $37.08 million +10.6%11.4%17 $11.48 2/28/20222,920,000 shares $34.05 million +4.3%10.3%18.2 $11.66 2/15/20222,800,000 shares $42.53 million +4.9%9.9%18.4 $15.19 1/31/20222,670,000 shares $31.83 million +6.8%10.2%18.4 $11.92 1/15/20222,500,000 shares $25 million +25.6%9.5%19.2 $10.00 12/31/20211,990,000 shares $37.71 million No Change7.6%16.8 $18.95 TNYA Short Interest - Frequently Asked Questions What is Tenaya Therapeutics' current short interest? Short interest is the volume of Tenaya Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 10,610,000 shares of TNYA short. 7.89% of Tenaya Therapeutics' shares are currently sold short. Learn More on Tenaya Therapeutics' current short interest. What is a good short interest ratio for Tenaya Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TNYA shares currently have a short interest ratio of 4.0. Learn More on Tenaya Therapeutics's short interest ratio. Which institutional investors are shorting Tenaya Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Tenaya Therapeutics: Group One Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Tenaya Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.89% of Tenaya Therapeutics' floating shares are currently sold short. Is Tenaya Therapeutics' short interest increasing or decreasing? Tenaya Therapeutics saw a increase in short interest in the month of July. As of July 31st, there was short interest totaling 10,610,000 shares, an increase of 4.0% from the previous total of 10,200,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Tenaya Therapeutics' float size? Tenaya Therapeutics currently has issued a total of 162,980,000 shares. Some of Tenaya Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tenaya Therapeutics currently has a public float of 134,430,000 shares. How does Tenaya Therapeutics' short interest compare to its competitors? 7.89% of Tenaya Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Tenaya Therapeutics: Kodiak Sciences Inc. (5.18%), Kamada Ltd. (0.15%), Erasca, Inc. (11.87%), Cullinan Therapeutics, Inc. (17.83%), COMPASS Pathways PLC Sponsored ADR (9.16%), Prothena Corporation plc (10.48%), Tectonic Therapeutic, Inc. (20.24%), PureTech Health PLC Sponsored ADR (0.01%), CryoPort, Inc. (6.08%), Gossamer Bio, Inc. (8.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Tenaya Therapeutics stock? Short selling TNYA is an investing strategy that aims to generate trading profit from Tenaya Therapeutics as its price is falling. TNYA shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tenaya Therapeutics? A short squeeze for Tenaya Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TNYA, which in turn drives the price of the stock up even further. How often is Tenaya Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TNYA, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Kodiak Sciences Short Interest Data Kamada Short Interest Data Erasca Short Interest Data Cullinan Therapeutics Short Interest Data COMPASS Pathways Short Interest Data Prothena Short Interest Data Tectonic Therapeutic Short Interest Data PureTech Health Short Interest Data CryoPort Short Interest Data Gossamer Bio Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TNYA) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenaya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenaya Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access